Man Group
OCDX

Man Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Man Group’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-54,981
Closed -$1.18M – 2446
2021
Q4 		$1.18M Sell
54,981
-14,515
-21% -$286K ﹤0.01% 1295
2021
Q3 		$1.28M Buy
69,496
+3,208
+5% +$64.6K ﹤0.01% 1286
2021
Q2 		$1.42M Buy
66,288
+27,471
+71% +$559K 0.01% 1307
2021
Q1 		$749K Buy
+38,817
New +$684K ﹤0.01% 1372

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Man Group's OCDX Position: Q1 2022 in Review

Man Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 54,981 shares — an estimated $1.18M sold.

Man Group first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $1.42M in Q2 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Man Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Man Group sold 54,981 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $1.18M.
  • Man Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
  • Man Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.42M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Man Group's 13F filing for Q1 2022, filed 16 May 2022.